Position in PFE
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$805,548
-$139,231 QoQ
Shares Held
33,453
-0.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#1,454
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Rodgers Brothers Inc. holds $137,046,562 across 11 Drug Manufacturers - General names. PFE ranks #7 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
55,538 | $66,613,948 | |
| 2 | ABBV |
AbbVie Inc.
|
127,464 | $32,075,040 | |
| 3 | JNJ |
Johnson & Johnson
|
63,682 | $16,173,317 | |
| 4 | MRK |
Merck & Co., Inc.
|
102,689 | $13,195,536 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
79,062 | $4,555,552 | |
| 6 | NVO |
Novo Nordisk A S
|
42,450 | $2,035,053 | |
| 7 | PFE |
Pfizer Inc
This page
|
33,453 | $805,548 | |
| 8 | AMGN |
Amgen Inc
|
1,897 | $686,941 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $805,548 | 33,453 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $944,779 | 33,646 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $840,150 | 33,741 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $873,836 | 34,295 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $856,568 | 35,337 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $970,091 | 38,283 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,016,178 | 38,303 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $1,139,599 | 39,378 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,108,651 | 39,623 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,112,580 | 40,093 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,171,378 | 40,687 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $2,477,898 | 74,703 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,481,365 | 67,649 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,704,387 | 66,284 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,345,152 | 65,284 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,077,815 | 70,334 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,711,152 | 70,783 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,647,994 | 31,833 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,946,110 | 32,957 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,417,480 | 32,957 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,440,832 | 87,866 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $2,087,500 | 57,618 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,010,488 | 54,618 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,018,351 | 54,996 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,804,911 | 55,196 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,759,783 | 53,915 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||